Join WilmerHale attorneys for a roundtable discussion covering the governance and SEC developments top of mind for life sciences company CLOs. Drawing on current developments and real-world experience, we will discuss board oversight of AI risks, recent SEC rulemaking and its potential impact on both public companies and those planning to go public, and insider trading trends—including shadow trading and prediction markets. The session will also cover emerging topics in this space and is designed to be interactive, with flexibility to address what participants are seeing in practice.

WilmerHale is a proud sponsor of the MassBio General Counsel Roundtable, a gathering of the top-ranking legal employees from MassBio's life sciences member companies.